17-acetamido-4-azasteroid derivatives as androgen receptor modulators

Details for Australian Patent Application No. 2004255200 (hide)

Owner Merck & Co., Inc.

Inventors Meissner, Robert S.; Dankulich, William P.; Mitchell, Helen J.

Agent Spruson & Ferguson

Pub. Number AU-A-2004255200

PCT Pub. Number WO2005/004807

Priority 60/483,664 30.06.03 US

Filing date 25 June 2004

Wipo publication date 20 January 2005

International Classifications

C07D 221/18 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/004807 Priority application(s): WO2005/004807

28 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255202-Oriented biopolymeric membrane for meningeal tissue repair

2004255199-Coumarin derivatives for the treatment of ophthalmic disorders